Acknowledgment for APICES collaboration in RE-SEARCH study

This month, we want to share the acknowledgment that APICES has received in the recent publication of RE-SEARCH Study, a study designed to describe the dosing patterns of regorafenib in a real-world population of patients with mCRC in a routine clinical practice setting in Spain, published in Clinical and Translational Oncology, in which APICES has collaborated in 𝘀𝘁𝘂𝗱𝘆 𝗱𝗲𝘀𝗶𝗴𝗻, 𝘀𝗲𝘁𝘂𝗽, 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁, 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴, 𝗱𝗮𝘁𝗮 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁, 𝘀𝘁𝗮𝘁𝗶𝘀𝘁𝗶𝗰𝗮𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 and medical writing.

This means a great motivation to all APICES team in order to give continuity to the implication we have in every project in which we collaborate. APICES is very proud of the recognition of our work, and we would like to thank Bayer and Ana María López Muñoz for giving us the opportunity to appear in the acknowledgements of the publication and congratulate them and all the investigators for their project success.

This is a retrospective observational, multicenter study to describe the dosing patterns of regorafenib in a real-world population of patients with metastatic colorectal cancer (mCRC) in a routine clinical practice setting in Spain, focusing on the starting dose of regorafenib.

You can find more information in the following link: https://link.springer.com/article/10.1007/s12094-024-03630-1